DE60031439D1 - Verwendung von carboxy verbindungen wie 2(4-acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chlorid als entzündungshemmende mittel - Google Patents

Verwendung von carboxy verbindungen wie 2(4-acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chlorid als entzündungshemmende mittel

Info

Publication number
DE60031439D1
DE60031439D1 DE60031439T DE60031439T DE60031439D1 DE 60031439 D1 DE60031439 D1 DE 60031439D1 DE 60031439 T DE60031439 T DE 60031439T DE 60031439 T DE60031439 T DE 60031439T DE 60031439 D1 DE60031439 D1 DE 60031439D1
Authority
DE
Germany
Prior art keywords
acetoxyphenyl
chloro
methyl
ethylammonium chloride
inflammatory agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60031439T
Other languages
English (en)
Other versions
DE60031439T2 (de
Inventor
Bosscher Karolien De
Berghe Wim Vanden
Guy Haegeman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universiteit Gent
Original Assignee
Universiteit Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universiteit Gent filed Critical Universiteit Gent
Application granted granted Critical
Publication of DE60031439D1 publication Critical patent/DE60031439D1/de
Publication of DE60031439T2 publication Critical patent/DE60031439T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60031439T 1999-12-21 2000-12-21 Verwendung von carboxy verbindungen wie 2(4-acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chlorid als entzündungshemmende mittel Expired - Lifetime DE60031439T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99204433 1999-12-21
EP99204433 1999-12-21
PCT/EP2000/013347 WO2001045693A1 (en) 1999-12-21 2000-12-21 Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chloride as anti-inflammatory agents

Publications (2)

Publication Number Publication Date
DE60031439D1 true DE60031439D1 (de) 2006-11-30
DE60031439T2 DE60031439T2 (de) 2007-09-13

Family

ID=8241039

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60031439T Expired - Lifetime DE60031439T2 (de) 1999-12-21 2000-12-21 Verwendung von carboxy verbindungen wie 2(4-acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chlorid als entzündungshemmende mittel

Country Status (8)

Country Link
US (1) US7053120B2 (de)
EP (1) EP1239850B1 (de)
AT (1) ATE342716T1 (de)
AU (1) AU2173101A (de)
CA (1) CA2395119A1 (de)
DE (1) DE60031439T2 (de)
ES (1) ES2274814T3 (de)
WO (1) WO2001045693A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001045693A1 (en) 1999-12-21 2001-06-28 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chloride as anti-inflammatory agents
GB0505509D0 (en) * 2005-03-17 2005-04-27 Ic Innovations Ltd Compounds
GB0526123D0 (en) 2005-12-22 2006-02-01 Univ Gent Synephrine derivatives useful as anti-inflammatory agents
CA2651423A1 (en) * 2006-03-23 2007-10-04 The Regents Of The University Of Michigan Compositions and methods for generating transgenic animals
US20090235373A1 (en) * 2007-02-08 2009-09-17 The Regents Of The University Of Michigan Method of delivery of nucleic acids to a developing embryo
US20090156672A1 (en) * 2007-12-17 2009-06-18 Northwestern University Substituted Phenyl Aziridine Precursor Analogs as Modulators of Steroid Receptor Activities
WO2009092796A1 (en) * 2008-01-23 2009-07-30 Universiteit Gent Synephrine derivatives for the treatment of cancer
WO2011154413A1 (en) * 2010-06-07 2011-12-15 Fritz-Lipmann-Insitut E. V. Leibniz-Institut Für Altersforschung Agent against glucocorticoid-induced osteoporosis
KR101567633B1 (ko) * 2013-07-03 2015-11-10 바이오스펙트럼 주식회사 감귤 미성숙과 추출물, 또는 시네프린 또는 이의 염을 유효성분으로 포함하는 염증성 피부질환 치료 또는 예방용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1600639A (en) * 1978-05-23 1981-10-21 Kali Chemie Pharma Gmbh Medicament preparation having resorption properties and method of producing the same
US4469689A (en) * 1983-03-30 1984-09-04 The Upjohn Company Sulfonate containing ester prodrugs of corticosteroids
US5086039A (en) * 1988-06-09 1992-02-04 Allelix Biopharmaceuticals, Inc. Pharmaceutical compositions and use thereof in treating inflammation
JPH0232016A (ja) * 1988-07-22 1990-02-01 Tsumura & Co Ｓｒｓ−ａ遊離抑制剤
DE4335523A1 (de) * 1993-10-19 1995-04-20 Ruetgerswerke Ag Antiallergikum
US5911988A (en) * 1995-04-28 1999-06-15 Bayer Corporation Method for treating asthma using SCF antibody
ATE453385T1 (de) * 1996-09-30 2010-01-15 Dennis Jones Regulation von körpergewicht durch materialien basierend auf zitrusvariationen
WO2001045693A1 (en) 1999-12-21 2001-06-28 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chloride as anti-inflammatory agents

Also Published As

Publication number Publication date
US20030055030A1 (en) 2003-03-20
WO2001045693A1 (en) 2001-06-28
ES2274814T3 (es) 2007-06-01
AU2173101A (en) 2001-07-03
US7053120B2 (en) 2006-05-30
CA2395119A1 (en) 2001-06-21
DE60031439T2 (de) 2007-09-13
EP1239850B1 (de) 2006-10-18
EP1239850A1 (de) 2002-09-18
ATE342716T1 (de) 2006-11-15

Similar Documents

Publication Publication Date Title
SE9504661D0 (sv) New compounds
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
DE60045508D1 (de) Dalda-analoge und ihre verwendung
AU2002225772A1 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
NO20100569L (no) Farmasoytiske formuleringer og anvendelse derav i forebyggelsen av slag, diabetes og/eller kongestivt hjertesvikt
SE9604786D0 (sv) New compounds
DK0902789T3 (da) Androstenderivater
ATE364605T1 (de) 3-aryloxy und 3-heteroaryloxy substituierte benzo(b) thiophene als therapeutische wirkstoffe mit pi3k aktivität
HUP0400553A2 (hu) Gyógyászati készítmények
DE60031439D1 (de) Verwendung von carboxy verbindungen wie 2(4-acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chlorid als entzündungshemmende mittel
SE0102440D0 (sv) New compound
NO20013414D0 (no) Ny anvendelse av melagatran
CA2417935A1 (en) Anti-inflammatory medicament
PT1147105E (pt) Derivado de piridil-4h-1,2,4-oxadiazina opticamente activo e sua utilizacao no tratamento de doencas vasculares
SE9504662D0 (sv) New compounds
DK1492539T3 (da) Statin-terapi til forögelse af kognitiv funktion
ATE275953T1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
TR199900013T2 (xx) Yeni bile�ikler.
DE60029946D1 (de) Arzneimittel gegen glomerulosclerose
EA200101157A1 (ru) 14β-H-СТЕРОЛЫ, СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И ПРИМЕНЕНИЕ ЭТИХ ПРОИЗВОДНЫХ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ, РЕГУЛИРУЮЩИХ МЕЙОЗ
HUP0402645A2 (hu) Egy glitazont és egy 4-oxobutánsavat tartalmazó gyógyászati készítmény és ennek alkalmazása cukorbetegség kezelésére
UA30143A (uk) Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань

Legal Events

Date Code Title Description
8364 No opposition during term of opposition